No connection

Search Results

NMTC vs PLUR

NMTC
NeuroOne Medical Technologies Corporation
BEARISH
Price
$0.73
Market Cap
$37.0M
Sector
Healthcare
AI Confidence
80%
PLUR
Pluri Inc.
BEARISH
Price
$3.51
Market Cap
$35.3M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
NMTC
--
PLUR
--
Forward P/E
NMTC
-2.61
PLUR
-1.85
P/B Ratio
NMTC
5.75
PLUR
-2.4
P/S Ratio
NMTC
3.16
PLUR
26.35
EV/EBITDA
NMTC
-4.55
PLUR
-2.58

Profitability

Gross Margin
NMTC
22.03%
PLUR
40.63%
Operating Margin
NMTC
-59.02%
PLUR
-3285.86%
Profit Margin
NMTC
-58.28%
PLUR
0.0%
ROE
NMTC
-146.27%
PLUR
--
ROA
NMTC
-63.4%
PLUR
-50.6%

Growth

Revenue Growth
NMTC
-11.7%
PLUR
7.0%
Earnings Growth
NMTC
--
PLUR
--

Financial Health

Debt/Equity
NMTC
0.04
PLUR
--
Current Ratio
NMTC
6.41
PLUR
0.43
Quick Ratio
NMTC
4.95
PLUR
0.39

Dividends

Dividend Yield
NMTC
--
PLUR
--
Payout Ratio
NMTC
0.0%
PLUR
0.0%

AI Verdict

NMTC BEARISH

NMTC presents a contradictory profile with a stable Piotroski F-Score of 6/9 and a very strong liquidity position (Current Ratio 6.41), yet it suffers from severe operational decay. The company is experiencing negative revenue growth (-11.70% YoY) and deep losses, evidenced by an ROE of -146.27%. While the balance sheet is clean with minimal debt (D/E 0.04), the bearish technical trend and consistent lack of profitability make it a high-risk speculative play.

Strengths
Very low Debt/Equity ratio (0.04)
Strong short-term liquidity (Current Ratio 6.41)
Stable Piotroski F-Score (6/9) indicating some internal financial improvements
Risks
Negative revenue growth (-11.70% YoY and -11.65% Q/Q)
Severe negative profit margins (-58.28%)
High Price-to-Book ratio (5.75) relative to lack of earnings
PLUR BEARISH

PLUR exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -2.40, indicating negative shareholder equity. The company is facing a severe liquidity crisis with a current ratio of 0.43, suggesting it cannot meet its short-term obligations. While recent quarterly earnings have beaten estimates, the operating margin of -3285.86% and a bearish technical trend (0/100) underscore a high risk of insolvency or significant shareholder dilution. The valuation is disconnected from fundamentals, trading at a high Price/Sales multiple of 26.35 despite sluggish revenue growth.

Strengths
Recent quarterly earnings beats (3 of last 4 quarters)
Positive YoY EPS growth (+71%)
Gross margin remains positive at 40.63%
Risks
Negative equity (P/B -2.40) indicating insolvency risk
Severe liquidity shortage (Current Ratio 0.43)
Catastrophic operating losses (-3285.86% margin)

Compare Another Pair

NMTC vs PLUR: Head-to-Head Comparison

This page compares NeuroOne Medical Technologies Corporation (NMTC) and Pluri Inc. (PLUR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile